PATHOLOGICAL ANGIOGENESIS IN VASCULAR TUMORS IS DRIVEN BY AKT1 AND INHIBITED BY TOPICAL RAPAMYCIN

被引:0
|
作者
Phung, Thuy L. [1 ]
Antonello, Zeus [1 ]
Gerald, Damien [1 ]
Perruzzi, Carole [1 ]
Rocuts, Alexander [1 ]
Hochman, Marcelo [2 ]
Cunningham, Michael [3 ]
Mihm, Martin [4 ]
Benjamin, Laura E. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Hemangioma Int Treatment Ctr, Charlotte, SC USA
[3] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源
FASEB JOURNAL | 2009年 / 23卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
634.13
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Akt1 Controls the Timing and Amplitude of Vascular Circadian Gene Expression
    Luciano, Amelia K.
    Santana, Jeans M.
    Velazquez, Heino
    Sessa, William C.
    JOURNAL OF BIOLOGICAL RHYTHMS, 2017, 32 (03) : 212 - 221
  • [22] GLYCATION OF AKT1 BY METHYLGLYOXAL AND PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS
    Wu, Lingyun
    Chang, Tuanjie
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 70 - 70
  • [23] AKT Inhibition in Solid Tumors With AKT1 Mutations (vol 35, pg 2251, 2017)
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 360 - 360
  • [24] Akt1 and Akt3 exert opposing roles in the regulation of vascular tumor growth
    Phung, Thuy L.
    Xue, Qi
    Nhek, Sokha
    Gerald, Damien
    Perruzzi, Carole
    Ayyaswamy, Sriram
    Du, Wa
    Geeganage, Sandaruwan
    Benjamin, Laura
    CANCER RESEARCH, 2014, 74 (19)
  • [25] Akt1 and Akt3 Exert Opposing Roles in the Regulation of Vascular Tumor Growth
    Phung, Thuy L.
    Du, Wa
    Xue, Qi
    Ayyaswamy, Sriram
    Gerald, Damien
    Antonello, Zeus
    Nhek, Sokha
    Perruzzi, Carole A.
    Acevedo, Isabel
    Ramanna-Valmiki, Rajesh
    Rodriguez-Waitkus, Paul
    Enayati, Ladan
    Hochman, Marcelo L.
    Lev, Dina
    Geeganage, Sandaruwan
    Benjamin, Laura E.
    CANCER RESEARCH, 2015, 75 (01) : 40 - 50
  • [26] The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling
    Sully, K.
    Akinduro, O.
    Philpott, M. P.
    Naeem, A. S.
    Harwood, C. A.
    Reeve, V. E.
    O'Shaughnessy, R. F.
    Byrne, C.
    ONCOGENE, 2013, 32 (27) : 3254 - 3262
  • [27] The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling
    K Sully
    O Akinduro
    M P Philpott
    A S Naeem
    C A Harwood
    V E Reeve
    R F O'Shaughnessy
    C Byrne
    Oncogene, 2013, 32 : 3254 - 3262
  • [28] Regulation of tumor angiogenesis by PIK3CA and AKT1 in ovarian cancer
    Xia, Chang
    Meng, Qiao
    Jiang, Bing-Hua
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis
    Ackah, E
    Yu, J
    Zoellner, S
    Iwakiri, Y
    Skurk, C
    Shibata, R
    Ouchi, N
    Easton, RM
    Galasso, G
    Birnbaum, MJ
    Walsh, K
    Sessa, WC
    JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08): : 2119 - 2127
  • [30] Modification of AKT1 by Methylglyoxal Promotes the Prodliferation of Vascular Smooth Muscle Cells
    Wu, Lingyun
    Chang, Tuanjie
    Wang, Rui
    Olson, Douglas J.
    Mousseau, Darrell D.
    Ross, Andrew R.
    HYPERTENSION, 2010, 56 (05) : E145 - E145